Composition:
Methotrexate 2.5 mg
Methora 2.5mg Tablet contains Methotrexate, an antineoplastic agent used to treat various cancers, severe psoriasis, rheumatoid arthritis, psoriatic arthritis, and juvenile rheumatoid arthritis. It belongs to the antimetabolite class of drugs and is a first-line treatment for RA. Methotrexate for psoriasis works by inhibiting inflammatory cell proliferation through the folate antagonism pathway and reducing inflammation via the adenosine signaling pathway. It also prevents cell division by blocking enzymes responsible for nucleotide synthesis. Methora 2.5mg Tablets are prescribed for cancers affecting the breast, head, neck, lungs, blood, bones, lymph, and uterus, as well as conditions like Crohn’s disease. By slowing cancer cell growth, it is effective in treating acute leukemias, non-Hodgkin’s lymphoma, and solid tumors in multiple organs.
*To be consumed as directed by physician.
Consuming alcohol while taking Methora 2.5mg Tablet is not recommended due to potential adverse interactions.
PregnancyMethora 2.5mg Tablet poses a high-risk during pregnancy. Studies indicate that it may cause serious harm to the developing fetus. Consult your doctor before use.
BreastfeedingThis medication is not considered safe for breastfeeding mothers, as it may lead to toxicity in infants. Medical advice is essential before use.
DrivingMethora 2.5mg Tablet can impair alertness, cause dizziness, or affect vision. If you experience these side effects, avoid driving or operating machinery.
Kidney HealthIndividuals with kidney disease should take Methora 2.5mg Tablet with caution, as dosage adjustments may be necessary. Regular kidney function monitoring is advised. Consult your doctor for guidance.
Liver HealthPatients with liver conditions should use Methora 2.5mg Tablet carefully. A dosage adjustment might be required. Seek medical advice before use.
